News | Patient Positioning Radiation Therapy | July 03, 2019

Civco Displaying Universal Couchtop ProForm Head & Neck Solution at AAPM

Couchtop allows effective proton therapy treatment of central nervous system cancers

Civco Displaying Universal Couchtop ProForm Head & Neck Solution at AAPM

July 3, 2019 — The upcoming release of Civco’s Universal Couchtop ProForm Head & Neck Solution will allow proton therapy centers direct access to effectively treat central nervous system (CNS) cancer patients.

The extension is quick and easy to attach and features a large, 121.5 cm junction-free and artifact-free treatment area. The ProForm contains a homogeneous treatment area with soft gradient edges that reduce beam degradation. ProForm accepts a thermoplastic mask with a smaller profile frame and pin similar to Civco’s Type-S system. The ProForm solution follows the Universal Couchtop release with IBA’s Proteus One and Proteus Plus. Utilizing the Universal Couchtop allows dosimetric consistency with computed tomography (CT) simulation, photon and proton treatment compatible models, improving clinic workflow.

Civco will display the Universal Couchtop at the 2019 American Association of Physicists in Medicine (AAPM) annual meeting, July 14-18 in San Antonio, Texas.

For more information: www.civcort.com

Related Content

IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and SCK CEN (Belgian Nuclear Research Center) announced a strategic R&D partnership to enable the production of Actinimum-225 (225Ac), a novel radioisotope which has significant potential in the treatment of cancer.
News | Radiation Oncology | September 17, 2021
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, a
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)

Getty Images

Feature | PET Imaging | September 14, 2021 | By Todd Sasser, Ph.D.
With a wealth of landmark studies in Breast, Cervical, Melanoma, Prostate, Colorectal, Oesophagus, Endocrine and Lung cancer, the ESMO Congress 2021 is a clear demonstration that oncology research has once again gathered momentum after being temporarily stopped in its tracks by the outbreak of the virus

Getty Images

News | Radiation Oncology | September 13, 2021
September 13, 2021 — At the opening press conference of the ...
Comment letters on the 2022 physician fee schedule and Radiation Oncology Model urge CMS to scale back extreme cuts that jeopardize access to life-saving cancer treatments

Getty Images

News | ASTRO | September 09, 2021
September 9, 2021 — The American Society for Radiation Oncology (AS...

Image of a STING protein, courtesy of UCLA Jonsson Comprehensive Cancer Center

News | PET Imaging | September 08, 2021
September 8, 2021 — A new study from scientists at the UCLA Jonsso...
An artificial intelligence (AI) program can spot signs of lung cancer on computed tomography (CT) scans a year before they can be diagnosed with existing methods, according to research presented at the European Respiratory Society International Congress.

Diagram showing details of the lung screening experiment. Image courtesy of the European Respiratory Society/Benoit Audelan

News | Artificial Intelligence | September 08, 2021
September 8, 2021 — An artificial intell...
At the recent 2021 AAPM Meeting in July, Sun Nuclear Corporation featured its comprehensive portfolio of independent, integrated quality management solutions for radiation therapy and diagnostic imaging.
News | Quality Assurance (QA) | September 02, 2021
September 2, 2021 — At the recent 2021 AAPM Meeting
Cedars-Sinai Cancer researchers have discovered that intestinal microorganisms help regulate anti-tumor immune responses to radiation treatments.

Getty Images

News | Radiation Therapy | September 01, 2021
September 1, 2021 — The study, published on Aug.